Cryoport-Lonza Partnership Featured in Contract Pharma and Biopharma Dive
Cryoport is expanding its impact on regenerative medicine development and distribution via a new partnership with Lonza.
November 12, 2019
Cryoport is expanding its impact on regenerative medicine development and distribution via a new partnership with Lonza.
October 15, 2019
“The past year has seen Cryoport establish multiple collaborations and expansions of its offering,” says a new article in BioPharma-Reporter, “due to the booming cell and gene therapy space and...
September 24, 2019
With just a handful of cell and gene therapies currently on the market, we’ve only seen the tip of the iceberg.
That’s how Cryoport’s Executive Director of Business Development, Ryan Carpentier,...
September 10, 2019
In a new article for Contract Pharma, Cryoport Executive Director of Business Development Ryan Carpentier explains the exciting new opportunities of CAR T-cell immunotherapy, which enables a...
September 10, 2019
New articles in Outsourcing Pharma and Pharmaceutical Commerce highlight the exciting benefits of the recently announced partnership between Cryoport and Vineti.
August 29, 2019
A new article in Life Science Leader chronicles the incredible achievements of Robert Hariri, M.D., Ph.D. The CEO of Celularity (a Cryoport-supported company) is also a neurosurgeon, a jet...
August 14, 2019
A special supply-chain focused edition of Outsourcing-Pharma highlights Cryoport’s new patent-pending technology and excellent Q2 earnings report.
June 26, 2019
According to the well-known physics principle, an object in motion tends to stay in motion. That's been especially true at Cryoport over the past six months, as we’ve celebrated one big milestone...
April 22, 2019
Cryoport has experienced remarkable growth in the past year: the company opened facilities in Amsterdam and Livingston, N.J., expanded its animal health services, hired several new employees, and...
April 16, 2019
Keeping life-saving medical specimens viable as they traverse the world is no simple task—and Cryoport does this hundreds of times each day. Monitoring the temperature, orientation, and location...
March 27, 2019
In recent interview with Technology Networks, Chief Commercial Officer Mark Sawicki discloses the importance of correctly transporting biological materials and how our best in class solutions...
March 06, 2019
Cryoport, a leading provider of temperature-controlled logistics solutions serving multiple markets including biopharmaceutical, IVF and surrogacy and animal health organisations worldwide, has...
January 16, 2019
Cryoport has announced a partnership with a Danish firm, Dacos A/S, to provide the full suite of Cryoport offerings. These offerings include their proprietary Cryoport Express® shippers, the...
November 13, 2018
Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Mark W. Sawicki, Ph.D., Chief Commercial officer...
November 05, 2018
Regenerative medicine advanced therapies in the form of cell and gene therapies are breaking new ground, providing patients the potential of treatment, reversal or even cure of serious and...
November 02, 2018
Cryoport recently unveiled its newest Global Logistics Center, based in Livingston, New Jersey with a ribbon-cutting ceremony attended by several of Cryoport’s clients, local dignitaries and...
October 29, 2018
Find out why the life science temperature-controlled space continues to grow apace in Asia Pacific and how supply chains can keep up with every-complex demands in a recent ASIA Outlook article by ...
October 26, 2018
Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, offers his take on why the life sciences cold chain space continues to grow apace in Asia Pacific and how supply chains can keep up...
October 04, 2018
Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry. The collaboration will support both...
August 20, 2018
The emergence of regenerative medicine as a viable therapy class has created an urgency to review and improve upon the current quality systems distribution standards that are employed in support...
July 17, 2018
Cryoport, Inc. announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled products into its global network. This integrated platform...
June 14, 2018
Chain of Compliance™ is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W....
April 10, 2018
Gasworld spoke to Jerry Shelton, Cryoport’s CEO, to find out how the latest regenerative medicines wouldn’t be possible without an often overlooked, yet extremely important component: logistics.s.
March 05, 2018
When it comes to shipping CAR-T cells, there are many factors that come in to play in order for drug companies to successfully mitigate risk – that’s where Cryoport comes in. Check out a recent...
February 21, 2018
Cryoport serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials to ensure a safe delivery, such as regenerative medicine, including immunotherapies, stem...
U.S. • The Netherlands • Singapore
Sales • +1 949.232.1900 | Support • +1 949.470.2300
©2019 Cryoport Systems, Inc. All rights reserved.
The first shippers certified for the delivery of human advanced therapies.